EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antioxidant and anti-inflammatory effects of allicin in the kidney of an experimental model of metabolic syndrome

Abraham Said Arellano Buendia, Juan Gabriel Juárez Rojas, Fernando García-Arroyo, Omar Emiliano Aparicio Trejo, Fausto Sánchez-Muñoz iD, Raúl Argüello-García, Laura Gabriela Sánchez-Lozada, Rafael Bojalil iD, Horacio Osorio-Alonso iD

PeerJ · 2023

DOI: 10.7717/peerj.16132 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, 2023. Verfasst von Abraham Said Arellano Buendia und 8 weiteren Autor:innen. Beteiligte Einrichtung: Doctorado en Ciencias Biológicas y de la Salud, Universidad Autónoma Metropolitana, Mexico, Xochimilco, Mexico. Hauptthemen laut MEDLINE: Metabolic Syndrome, Glucose Intolerance, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto Nacional de Cardiología Ignacio Chávez.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Recent studies have suggested that metabolic syndrome (MS) encompasses a group of risk factors for developing chronic kidney disease (CKD). This work aimed to evaluate the antioxidant and anti-inflammatory effects of allicin in the kidney from an experimental model of MS.

Methods

Male Wistar rats (220–250 g) were used, and three experimental groups ( n = 6) were formed: control (C), metabolic syndrome (MS), and MS treated with allicin (16 mg/Kg/day, gastric gavage) (MS+A). MS was considered when an increase of 20% in at least three parameters (body weight, systolic blood pressure (SBP), fasting blood glucose (FBG), or dyslipidemia) was observed compared to the C group. After the MS diagnosis, allicin was administered for 30 days.

Results

Before the treatment with allicin, the MS group showed more significant body weight gain, increased SBP, and FBG, glucose intolerance, and dyslipidemia. In addition, increased markers of kidney damage in urine and blood. Moreover, the MS increased oxidative stress and inflammation in the kidney compared to group C. The allicin treatment prevented further weight gain, reduced SBP, FBG, glucose intolerance, and dyslipidemia. Also, markers of kidney damage in urine and blood were decreased. Further, the oxidative stress and inflammation were decreased in the renal cortex of the MS+A compared to the MS group.

Conclusion

Allicin exerts its beneficial effects on the metabolic syndrome by considerably reducing systemic and renal inflammation as well as the oxidative stress. These effects were mediated through the Nrf2 pathway. The results suggest allicin may be a therapeutic alternative for treating kidney injury induced by the metabolic syndrome risk factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromeGlucose IntoleranceRenal Insufficiency, ChronicRatsAnimalsMaleAntioxidantsRats, WistarKidneyBody WeightModels, TheoreticalInflammationAnti-Inflammatory AgentsDisulfidesSulfinic Acids

Stichwörter der Autor:innen

AllicinChronic kidney diseaseHypertensionInflammationMetabolic syndromeOxidative stress

Substanzen

AntioxidantsAnti-Inflammatory AgentsallicinDisulfidesSulfinic Acids

Autor:innen und Institutionen

  • Doctorado en Ciencias Biológicas y de la Salud, Universidad Autónoma Metropolitana, Mexico, Xochimilco, Mexico.
  • Fisiopatología Cardio-Renal, Instituto Nacional de Cardiología Ignacio Chávez, Mexico, Tlalpan, México.
  • Endocrinología, Instituto Nacional de Cardiología Ignacio Chávez, Mexico, Tlalpan, México.
  • Inmunología, Instituto Nacional de Cardiología Ignacio Chávez, Mexico, Tlalpan, México.
  • Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados del IPN, México, Gustavo A. Madero, México.
  • Atención a la Salud, Universidad Autónoma Metropolitana, Mexico, Xochimilco, México.

ORCID-Profile: Fausto Sánchez-Muñoz, Rafael Bojalil, Horacio Osorio-Alonso

Förderung

  • Instituto Nacional de Cardiología Ignacio Chávez

Zitieren

APA

Arellano Buendia, A. S., Juárez Rojas, J. G., García-Arroyo, F., Aparicio Trejo, O. E., Sánchez-Muñoz, F., Argüello-García, R., Sánchez-Lozada, L. G., Bojalil, R., & Osorio-Alonso, H. (2023). Antioxidant and anti-inflammatory effects of allicin in the kidney of an experimental model of metabolic syndrome. PeerJ. https://doi.org/10.7717/peerj.16132

Vancouver

Arellano Buendia AS, Juárez Rojas JG, García-Arroyo F, Aparicio Trejo OE, Sánchez-Muñoz F, Argüello-García R, et al. Antioxidant and anti-inflammatory effects of allicin in the kidney of an experimental model of metabolic syndrome. PeerJ. 2023. doi:10.7717/peerj.16132

BibTeX
@article{ArellanoBuendia2023,
  author = {Arellano Buendia, Abraham Said and Juárez Rojas, Juan Gabriel and García-Arroyo, Fernando and Aparicio Trejo, Omar Emiliano and Sánchez-Muñoz, Fausto and Argüello-García, Raúl and Sánchez-Lozada, Laura Gabriela and Bojalil, Rafael and Osorio-Alonso, Horacio},
  title = {Antioxidant and anti-inflammatory effects of allicin in the kidney of an experimental model of metabolic syndrome},
  journal = {PeerJ},
  year = {2023},
  doi = {10.7717/peerj.16132}
}
Kostenlos starten →